Part I. The Ovarian Follicular Apparatus: Operational Characteristics<br>1. Follicle Selection in Mammalian Ovaries<br>2. Regulation of follicle formation and development by ovarian signaling pathway<br>3. Human Folliculogenesis Revisited: The Menstrual Cycle Visualized by Ultrasonography<br>4. Development of the Mammalian Ovary and Follicles<br>5. Organization of Ovarian Steroidogenic Cells and Cholesterol Metabolism <br>6. Inhibin, Activin and Follistatin in Ovarian Physiology<br>7. Cell-cell Interactions in the Ovarian Follicles: Role of TGF-beta Superfamily Members<br>8. Mutations and Polymorphisms, and their Functional Consequences, in Gonadotropin and Gonadotropin Receptor Genes <br>9. Environmentally Induced Epigenetic Transgenerational Inheritance of Ovarian Disease<br>Part II. Oocyte Maturation and Ovulation<br>10. Mammalian Oogenesis – the fragile foundation of the next generation<br>11. Regulation of Mammalian Oocyte Maturation<br>12. Oocyte Meiotic Maturation<br>13. Gene Expression During Oogenesis and Oocyte Development<br>Part III. The Corpus Luteum<br>15. Molecular Regulation of Progesterone Production in Corpus Luteum<br>16. Corpus Luteum Formation <br>17. Luteolysis and The Corpus Luteum of Pregnancy<br>Part IV. Novel Experimental Models<br>18. Transgenic Mouse Models in the Study of Ovarian Function <br>19. Genome-Wide Association Studies of Ovarian Function Disorders<br>20. Mitchondria Research in Human Reproduction <br>21. The Role of Mitochondria in Reproductive Function and Assisted Reproduction <br>Part V. Human Ovarian Pathophysiology: Select Aspects<br>22. Ovarian Hyperstimulation Syndrome<br>23. The Role of GnRH Agonist Triggering in GnRH Antagonist-Based Ovarian Stimulation Protocols<br>24. The Ovarian Factor in Assisted Reproductive Technology<br>25. The Role of Antimullerian Hormone in Assisted Reproduction <br>26. Polycystic Ovary Syndrome<br>27. Genetic and Environmental Factors in the Aetiology of Polycystic Ovary Syndrome<br>28. Germ Cell Failure and Ovarian Resistance: Human Genes and Disorders <br>29. Environmental Contaminants and Ovarian Toxicity <br>30. Autologous Transplantation of Human Ovarian Tissue <br>31. Oncofertility: Preservation of ovarian function after a cancer diagnosis<br>Part VI. Human Ovarian Cancer<br>32. Ovarian cancers: their varied origins and pathologically implicated microenvironment<br>33. Phenotypic Plasticity and the Origins and Progression of Ovarian Cancer <br>34. Novel Therapeutic Approaches and Targets for Ovarian Cancer<br>35. Molecular and Cellular Basis of Chemoresistance in Ovarian Cancer